Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices 14543 

the meeting, depending on the volume 

of comments received and the time 

required to process them in accordance 

with privacy regulations and other 

applicable Federal policies. The 

Committee is not able to individually 

respond to comments. All public 

comments become part of the public 

record. Attachments of copyrighted 

publications are not permitted, but web 

links or citations for any copyrighted 

works cited may be provided. For public 

comment guidelines, see: https://

iacc.hhs.gov/meetings/publiccomments/guidelines/. 

Technical Issues 

If you experience any technical 

problems with the webcast please email 

IACCPublicInquiries@mail.nih.gov. 

Meeting schedule subject to change. 

Disability Accommodations 

All IACC Full Committee Meetings 

provide Closed Captioning through the 

NIH videocast website. Individuals 

whose full participation in the meeting 

will require special accommodations 

(e.g., sign language or interpreting 

services, etc.) must submit a request to 

the Contact Person listed on the notice 

at least seven (7) business days prior to 

the meeting. Such requests should 

include a detailed description of the 

accommodation needed and a way for 

the IACC to contact the requester if 

more information is needed to fill the 

request. Special requests should be 

made at least seven (7) business days 

prior to the meeting; last-minute 

requests may be made but may not be 

possible to accommodate. 

More Information 

Information about the IACC is 

available on the website: http://

www.iacc.hhs.gov. 

Dated: March 10, 2022. 

Melanie Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05468 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Neurological Disorders and Stroke 

Council. 

The meeting will be open to the 

public as indicated below. Individuals 

who plan to participate and need 

special assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council. 

Date: May 18–19, 2022. 

Open: May 18, 2022, 1:00 p.m. to 5:30 p.m. 

Agenda: Report by the Director, NINDS; 

Report by the Director, Division of 

Extramural Activities; Administrative and 

Program Developments; and Overview of the 

NINDS Intramural Program. 

Open session will be videocast from this 

link: https://videocast.nih.gov/. 

Closed: May 19, 2022, 1:00 p.m. to 5:00 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Closed: May 19, 2022, 5:00 p.m. to 5:30 

p.m. 

Agenda: To review and evaluate the 

Division of Intramural Research Board of 

Scientific Counselors’ Reports. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive Blvd., 

Rockville, MD 20852 (Virtual Meeting). 

Contact Person: Robert Finkelstein, Ph.D., 

Director of Extramural Research, National 

Institute of Neurological Disorders and 

Stroke, NIH, 6001 Executive Blvd., Suite 

3309, MSC 9531, Bethesda, MD 20892, (301) 

496–9248, finkelsr@ninds.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice at 

least 10 days in advance of the meeting. 

The statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.ninds.nih.gov, where an agenda 

and any additional information for the 

meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: March 9, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05465 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for the 

treatment of cancer. The outcome of the 

evaluation will provide information to 

internal NCI committees that will 

decide whether NCI should support 

requests and make available contract 

resources for development of the 

potential therapeutic to improve the 

treatment of various forms of cancer. 

The research proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the 

proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; FEB2022 

Cycle 40 NExT SEP Committee Meeting. 

Date: April 18, 2022. 

Time: 9:00 a.m. to 3:00 p.m. 

Agenda: To evaluate the NCI Experimental 

Therapeutics Program Portfolio. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, Room 3A44, 

Bethesda, Maryland 20892 (WebEx Meeting). 

Contact Persons: Barbara Mroczkowski, 

Ph.D., Executive Secretary, Discovery 

Experimental Therapeutics Program, 

National Cancer Institute, NIH, 31 Center 

Drive, Room 3A44, Bethesda, MD 20817, 

(301) 496–4291, mroczkoskib@mail.nih.gov. 

Toby Hecht, Ph.D., Executive Secretary, 

Development Experimental Therapeutics 

Program, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 3W110, 

Rockville, MD 20850, (240) 276–5683, 

toby.hecht2@nih.gov. 


khammond on DSKJM1Z7X2PROD with NOTICES
14544 Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 10, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05464 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer Institute 

Board of Scientific Advisors. 

The meeting will be held as a virtual 

meeting and is open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov/). 

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: March 28, 2022. 

Time: 1:00 p.m. to 5:30 p.m. 

Agenda: Director’s Report; RFA, RFP, and 

PAR Concept Reviews; and Scientific 

Presentations. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20850 (Virtual Meeting). 

Date: March 29, 2022. 

Time: 1:00 p.m. to 5:30 p.m. 

Agenda: RFA, RFP, and PAR Concept 

Reviews; and Scientific Presentations. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Rockville, 

MD 20852 (Virtual Meeting). 

Contact Person: Paulette S. Gray, Ph.D., 

Director, Division of Extramural Activities, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center, Drive, 7th Floor, Room 7W444, 

Bethesda, MD 20892, 240–276–6340, grayp@

mail.nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: BSA: 

http://deainfo.nci.nih.gov/advisory/bsa/ 

bsa.htm, where an agenda and any 

additional information for the meeting 

will be posted when available. 

This notice is being published less 

than 15 days prior to the meeting due 

to scheduling difficulties. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: March 10, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05467 Filed 3–14–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; NIH COVID–19 

Vaccination Status Form Extension 

AGENCY: National Institutes of Health, 

Department of Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Dr. Jessica 

McCormick-Ell, Ph.D., SM (NRCM), 

CBSP, RBP, NIH/ORS/SR/DOHS, Bldg. 

13/3W80, Bethesda, MD, 20892–5760 or 

call non-toll-free number (301) 496– 

0590 or email your request, including 

your address to: jessica.mccormick-ell@

nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on November 22, 2021 (86 FR 

66319), and allowed 60 days for public 

comment. No public comments were 

received. The purpose of this notice is 

to allow an additional 30 days for public 

comment. The Office of Research 

Services, National Institutes of Health, 

may not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: NIH COVID–19 

Vaccination Status Form, REVISION, 

0925–0771, exp., 3/31/2022, Office of 

Research Services (ORS), National 

Institutes of Health (NIH). 

Need and Use of Information 

Collection: This revision request 

includes two new forms as NIH is 

implementing a building entry protocol 

where all people, Federal Government 

employees, contractors, patients, and 

visitors, will answer questions about 

COVID exposure every day. The NIH 

COVID–19 Vaccination Status Form will 

continue to ensure the safety of the 

Federal workplace consistent with 

Executive Order 14042, Ensuring 

Adequate COVID Safety Protocols for 

Federal Contractors, Executive Order 

14043, Requiring Coronavirus Disease 

2019 Vaccination for Federal 

Employees, the COVID–19 Workplace 

Safety: Agency Model Safety Principles 

established by the Safer Federal 

Workforce Task Force, and guidance 

from the Centers for Disease Control and 

Prevention (CDC) and the Occupational 

Safety and Health Administration 

(OSHA). The proposed information 

collection will continue to be used to 

ensure compliance with vaccination 

requirements in the authorities above, 

generate the list of persons required to 

be tested on a routine basis, and will 

provide important information 


khammond on DSKJM1Z7X2PROD with NOTICES